|
Since 1984, Lavipharm Group has embarked on an international course. France was the first "stop" followed by the USA and Cyprus. The Group's activities focus on research as well as international marketing.
It is designed on two strategies: the worldwide promotion and marketing of existing pharmaceutical and skincare products developed in its in-house R&D facilities and the application of Lavipharm's innovative technologies for the development of products on behalf of other major pharmaceutical companies worldwide.
The Group collaborates with multinational companies in order to hold a leading position in the international pharmaceutical market with well-known products , developing simultaneously the difficult but essential Research & Development sector.
International Activity Centers
USA
Research & Development of new drug delivery systems
Business development of pharmaceuticals
France
Research & Development of supercritical fluid (SCF)
Business Development of cosmetics
Cyprus
Commercial activity in Cyprus and the Middle East
|